Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cost of Revenue (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Cost of Revenue for 6 consecutive years, with $419.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue rose 19.98% year-over-year to $419.1 million, compared with a TTM value of $1.5 billion through Sep 2025, up 10.97%, and an annual FY2024 reading of $1.4 billion, up 6.86% over the prior year.
  • Cost of Revenue was $419.1 million for Q3 2025 at Aveanna Healthcare Holdings, up from $378.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $419.1 million in Q3 2025 and bottomed at $285.5 million in Q2 2021.
  • Average Cost of Revenue over 5 years is $337.5 million, with a median of $330.7 million recorded in 2023.
  • The sharpest move saw Cost of Revenue decreased 14.82% in 2023, then increased 19.98% in 2025.
  • Year by year, Cost of Revenue stood at $289.5 million in 2021, then soared by 33.97% to $387.9 million in 2022, then decreased by 14.82% to $330.4 million in 2023, then rose by 5.37% to $348.2 million in 2024, then grew by 20.38% to $419.1 million in 2025.
  • Business Quant data shows Cost of Revenue for AVAH at $419.1 million in Q3 2025, $378.8 million in Q2 2025, and $375.7 million in Q1 2025.